<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Biomed Res Int</journal-id><journal-id journal-id-type="iso-abbrev">Biomed Res Int</journal-id><journal-id journal-id-type="publisher-id">BMRI</journal-id><journal-title-group><journal-title>BioMed Research International</journal-title></journal-title-group><issn pub-type="ppub">2314-6133</issn><issn pub-type="epub">2314-6141</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23509708</article-id><article-id pub-id-type="pmc">3590581</article-id><article-id pub-id-type="doi">10.1155/2013/314091</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Heparin and Carboxymethylchitosan Metal Nanoparticles: An Evaluation of Their Cytotoxicity</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bava</surname><given-names>Adriana</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Cappellini</surname><given-names>Francesca</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Pedretti</surname><given-names>Elisa</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Rossi</surname><given-names>Federica</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Caruso</surname><given-names>Enrico</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Vismara</surname><given-names>Elena</given-names></name><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref><xref ref-type="aff" rid="I4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Chiriva-Internati</surname><given-names>Maurizio</given-names></name><xref ref-type="aff" rid="I5">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Bernardini</surname><given-names>Giovanni</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Gornati</surname><given-names>Rosalba</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I4">
<sup>4</sup>
</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff id="I1"><sup>1</sup>Dipartimento di Biotecnologie e Scienze della Vita, Universit&#x000e0; dell'Insubria, 21100 Varese, Italy</aff><aff id="I2"><sup>2</sup>Dipartimento di Scienze Teoriche ed Applicate, Universit&#x000e0; dell'Insubria, 21100 Varese, Italy</aff><aff id="I3"><sup>3</sup>Dipartimento di Chimica, Materiali e Ingegneria Chimica &#x0201c;G. Natta,&#x0201d; Politecnico di Milano, 20131 Milano, Italy</aff><aff id="I4"><sup>4</sup>Interuniversity Center &#x0201c;The Protein Factory,&#x0201d; Politecnico di Milano, ICRM-CNR Milano and Universit&#x000e0; dell'Insubria, 20131 Milano, Italy</aff><aff id="I5"><sup>5</sup>Division of Oncology and Hematology, Texas Tech University Health Sciences Center, Lubbock, TX 79409, USA</aff><author-notes><corresp id="cor1">*Rosalba Gornati: <email>rosalba.gornati@uninsubria.it</email></corresp><fn fn-type="other"><p>Academic Editor: Xudong Huang</p></fn></author-notes><pub-date pub-type="ppub"><year>2013</year></pub-date><pub-date pub-type="epub"><day>18</day><month>2</month><year>2013</year></pub-date><volume>2013</volume><elocation-id>314091</elocation-id><history><date date-type="received"><day>23</day><month>10</month><year>2012</year></date><date date-type="rev-recd"><day>3</day><month>1</month><year>2013</year></date><date date-type="accepted"><day>3</day><month>1</month><year>2013</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2013 Adriana Bava et al.</copyright-statement><copyright-year>2013</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/3.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>In the search for noninvasive diagnostic techniques and new therapies, &#x0201c;nanosystems&#x0201d;, which are capable of binding and targeting bioactive molecules, are becoming increasingly important. In this context, biocompatible coatings are gaining interest, not only for their biological effects but also because they are considered capable to mask nanoparticle toxicity. In this work, we have compared the toxicity of nanoparticles coated with heparin and carboxymethylchitosan in the SKOV-3 cell line. Our results indicate that heparin and carboxymethylchitosan coatings do not guarantee the decrease of nanoparticle intrinsic toxicity which is often envisaged. Nonetheless, these coatings provide the opportunity for further functionalization with a variety of biomolecules for their use in theranostics.</p></abstract></article-meta></front><body><sec id="sec1"><title>1. Introduction </title><p>Nanomedicine, the application of nanotechnology in healthcare, offers numerous and promising possibilities to significantly improve medical diagnosis and therapy. New sensitive diagnostic devices, in fact, will permit very early personal risk assessment, and the abatement of costs for the disease treatment is a must for healthcare. Due to its high potential, nanomedicine holds the promise to greatly improve the efficacy of pharmaceutical therapy, reduce side effects, and make drug administration more convenient [<xref rid="B1" ref-type="bibr">1</xref>].</p><p>In this context, nanoparticles (NPs), particularly magnetic nanoparticles (MNPs), coated with biodegradable polymers, are attracting widespread attention for targeted therapy and imaging. These coatings can stabilize the NP systems also in hydrophilic fluids, minimize opsonization by the mononuclear phagocytic system, and prolong blood circulation [<xref rid="B2" ref-type="bibr">2</xref>&#x02013;<xref rid="B7" ref-type="bibr">7</xref>]. Furthermore, this surface layer can be functionalized with a variety of biological moieties for tumor-specific targeting [<xref rid="B8" ref-type="bibr">8</xref>&#x02013;<xref rid="B10" ref-type="bibr">10</xref>].</p><p>Among the biological molecules used for NP coating, chitosan, particularly carboxymethylchitosan (CMCS), and heparin appear very interesting also because they are considered capable to mask NP toxicity [<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B12" ref-type="bibr">12</xref>]. We should not, in fact, oversee the toxicity of cobalt and nickel oxide NPs [<xref rid="B13" ref-type="bibr">13</xref>&#x02013;<xref rid="B16" ref-type="bibr">16</xref>] nor their potential effect on the environment [<xref rid="B17" ref-type="bibr">17</xref>]. Even though heparin is predominantly used as anticoagulant, its ability to interact with proteins makes it very attractive. NPs coated with heparin (NP@heparin) are extensively studied because of their several biomedical applications ranging from tissue engineering to biosensors passing for its use in cancer therapy [<xref rid="B3" ref-type="bibr">3</xref>]. As well as heparin, also chitosan NPs have demonstrated anticancer activity <italic>in vitro </italic>as well as <italic>in vivo</italic> even though the mechanisms remain to be elucidated [<xref rid="B18" ref-type="bibr">18</xref>].</p><p>In this paper, we have reported cytotoxicity and uptake of some transition metal oxide NPs (Co<sub>3</sub>O<sub>4</sub>, Fe<sub>3</sub>O<sub>4</sub>, and NiO) coated with heparin and of Fe<sub>3</sub>O<sub>4 </sub>NPs coated with CMCS (Fe<sub>3</sub>O<sub>4</sub>@CMCS) in SKOV-3 cell. Transition metal NPs are especially used to enhance surface electrochemical reactivity to further improve the performance of lithium-ion batteries [<xref rid="B19" ref-type="bibr">19</xref>] as well as in catalysis [<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B21" ref-type="bibr">21</xref>]. Nevertheless, the therapeutic use of transition metal conjugates was already known in the sixteenth century because of their different oxidation states and ability to interact with negatively charged molecules forming chelation complexes [<xref rid="B22" ref-type="bibr">22</xref>]. </p><p>The results here reported indicate that heparin and CMCS alone did not show any cytotoxicity effect at the concentration used in the experiments. Unfortunately, they did not seem to be able to drastically reduce NP toxicity.</p></sec><sec id="sec2"><title>2. Materials and Methods</title><sec id="sec2.1"><title>2.1. Chemicals</title><p>Iron oxide (Fe<sub>3</sub>O<sub>4</sub>), cobalt oxide (Co<sub>3</sub>O<sub>4</sub>) and nickel oxide (NiO) NPs (&#x0003c;50&#x02009;nm particle size), chitosan powder (75% degree of acetylation), monochloroacetic acid, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC&#x000b7;HCl), and N-hydroxysuccinimide (NHS) were purchased from Sigma-Aldrich, Milan, Italy. Heparin, in the form of sodium salt, was kindly provided by LDO Company, Trino Vercellese, Italy. CellTiter-Glo Luminescent Cell Viability Assay was purchased from Promega, Milan, Italy. Isopropanol was purchased from J.T.Baker, Milan, Italy. All other reagents, analytical or cell culture grade, were purchased from Sigma-Aldrich, Milan, Italy. The Milli-Q ultrapure water was used. </p></sec><sec id="sec2.2"><title>2.2. Nanoparticles Characterization</title><p>The particle size distribution was studied by transmission electron microscopy (TEM) using a 90&#x02009;keV JEOL-1010 electron microscope (Tokyo, Japan). TEM samples were prepared by placing 10&#x02009;<italic>&#x003bc;</italic>L of a dilute suspension of Fe<sub>3</sub>O<sub>4</sub> nanoparticles in ethanol on a carbon-coated copper grid and allowing the solvent to evaporate at room temperature. The average particle size (<italic>D</italic>
<sub>TEM</sub>) and distribution were evaluated by measuring the largest internal dimension of 100 particles.</p></sec><sec id="sec2.3"><title>2.3. Synthesis of Carboxymethylchitosan (CMCS)</title><p>CMCS was prepared as reported by Zhu et al. [<xref rid="B23" ref-type="bibr">23</xref>]. The chemical structures of chitosan and CMCS are reported in <xref ref-type="fig" rid="fig1">Figure 1</xref>.</p></sec><sec id="sec2.4"><title>2.4. Coating of Metal Nanoparticles</title><sec id="sec2.4.1"><title>2.4.1. NP@heparin</title><p>A suspension of NPs (Co<sub>3</sub>O<sub>4</sub> or Fe<sub>3</sub>O<sub>4</sub> or NiO) in distilled water (100&#x02009;mg/5&#x02009;mL) obtained by ultrasonication for 5&#x02009;min (Sonica 5300MH-Soltec) was transferred into a solution of heparin, (1.045&#x02009;g/25&#x02009;mL, pH 7 adjusted with 0.01&#x02009;N NaOH). The mixture was stirred overnight (130&#x02009;rpm, 25&#x000b0;C, Julabo SW22). Co<sub>3</sub>O<sub>4</sub>@heparin and NiO@heparin were separated by centrifugation (1&#x02009;h, 6300&#x02009;&#x000d7;g, Hettich Zentrifugen-Rotina 35&#x02009;F), while Fe<sub>3</sub>O<sub>4</sub>@heparin was separated by a neodymium magnet (NdFeB Nickel plated, magnetization N45). NP@heparin were collected in diethyl ether, recovered after solvent elimination and dried at 50&#x000b0;C for 1&#x02009;h.</p></sec><sec id="sec2.4.2"><title>2.4.2. Fe<sub>3</sub>O<sub>4</sub>@CMCS Electrostatic Bound</title><p>A suspension of 100&#x02009;mg of Fe<sub>3</sub>O<sub>4</sub>NPs in 5&#x02009;mL water was prepared by ultrasonic bath for 10&#x02009;min. Separately, 100&#x02009;mg of CMCS was dissolved in 20&#x02009;mL of water using a magnetic stirrer until complete dissolution, then added to the Fe<sub>3</sub>O<sub>4</sub> NPs dispersion and mixed by ultrasonic bath at 0&#x000b0;C for 1&#x02009;h. After reaction, the Fe<sub>3</sub>O<sub>4</sub>@CMCS was separated from unbound CMCS by a neodymium magnet, washed several times with water, and centrifuged at 15000&#x02009;&#x000d7;g, 20&#x02009;min. The pellet was resuspended in ethyl alcohol then, after anhydrification, Fe<sub>3</sub>O<sub>4</sub>@CMCS was dried overnight at 50&#x000b0;C. </p></sec><sec id="sec2.4.3"><title>2.4.3. Fe<sub>3</sub>O<sub>4</sub>@CMCS-Covalent Bound</title><p>The covalent immobilization of CMCS on Fe<sub>3</sub>O<sub>4</sub>NPs was conducted following Liang and Zhang method [<xref rid="B24" ref-type="bibr">24</xref>] with some modifications. Briefly, 75&#x02009;mg of Fe<sub>3</sub>O<sub>4</sub>NPs were added to 4&#x02009;mL of sodium phosphate buffer (200&#x02009;mM, pH 5) containing 25&#x02009;mg of EDC<italic>&#x000b7;</italic>HCl and 20&#x02009;mg of NHS; the mixture was left in an ultrasonic bath for 30&#x02009;min. The Fe<sub>3</sub>O<sub>4</sub>NPs activated were separated from excess of reagents by magnetic decantation, then resuspended in 3&#x02009;mL of 200&#x02009;mM sodium phosphate buffer (pH 7) by sonication for 10&#x02009;min. 1&#x02009;mL of CMCS solution (25&#x02009;mg/mL in 200&#x02009;mM sodium phosphate buffer, pH 7) was added to the suspension of the NPs and the reaction mixture was sonicated for 3&#x02009;h. Finally, the Fe<sub>3</sub>O<sub>4</sub>@CMCS was recovered by magnet, washed with water, and dried overnight at 50&#x000b0;C.</p></sec><sec id="sec2.4.4"><title>2.4.4. Determination of Unbound Fe</title><p> 5&#x02009;mg of Fe<sub>3</sub>O<sub>4</sub>NPs, or Fe<sub>3</sub>O<sub>4</sub>@heparin, or Fe<sub>3</sub>O<sub>4</sub>@CMCS electrostatically bound or Fe<sub>3</sub>O<sub>4</sub>@CMCS covalently bound were resuspended in 5&#x02009;mL of H<sub>2</sub>O, sonicated for 20&#x02009;min, and left at 37&#x000b0;C for 72&#x02009;h. Afterwards, NP systems were separated from the supernatant by a neodymium magnet, centrifuged twice at 15000&#x02009;&#x000d7;g for 15&#x02009;min at 4&#x000b0;C, then ultracentrifuged at 300000&#x02009;&#x000d7;g for 2&#x02009;h at 4&#x000b0;C. After centrifugation, supernatants were filtered using a 0.22&#x02009;<italic>&#x003bc;</italic>m pore size membrane. The amount of Fe (II), eventually released in solution, was determined by complexometric analysis with the <italic>o</italic>-phenanthroline [<xref rid="B25" ref-type="bibr">25</xref>]. The Fe (II), in the presence of <italic>o</italic>-phenanthroline, form the stable red-orange complex [(C<sub>12</sub>H<sub>18</sub>N<sub>2</sub>)<sub>3</sub>Fe]<sup>2+</sup>. The intensity of the color does not vary in the range of pH between 3 and 9. The maximum absorption wavelength occurs at 510&#x02009;nm. The possible Fe (III) is reduced to Fe (II) by treatment with hydroxylamine hydrochloride.</p></sec></sec><sec id="sec2.5"><title>2.5. FT-IR Spectra Analysis</title><p>Characterization of the samples was performed using the solid phase Fourier transform infrared spectroscopy (FT-IR). Spectra were obtained using a Nicolet, Avatar 360. Samples were mixed with infrared grade KBr in a proportion of 2&#x02009;:&#x02009;100 (w/w).</p></sec><sec id="sec2.6"><title>2.6. Cell Culture</title><p>SKOV-3 cell line was maintained as adherent cells in RPMI 1640 medium, at 37&#x000b0;C in a humidified 5% CO<sub>2</sub> atmosphere. Medium was supplemented with 10% fetal bovine serum and 2&#x02009;mM L-glutamine. Cells were passaged as needed using 0.5% trypsin EDTA. </p></sec><sec id="sec2.7"><title>2.7. Cell Viability</title><p>Cell viability was determined measuring ATP content by the CellTiter-Glo Assay according to the manufacturer's instructions. In details, 200&#x02009;<italic>&#x003bc;</italic>L of cell suspension (containing 2 &#x000d7; 10<sup>4</sup>, 1 &#x000d7; 10<sup>4</sup>, 5 &#x000d7; 10<sup>3</sup>, 25 &#x000d7; 10<sup>2</sup> cells depending of the exposure time) were seeded into 96-well assay plates and cultivated for 24&#x02009;h at 37&#x000b0;C in 5% CO<sub>2</sub> to equilibrate and become attached prior to the treatment. Then, cells were exposed to 100&#x02009;<italic>&#x003bc;</italic>L of increasing concentrations of heparin, NP@heparin, CMCS, Fe<sub>3</sub>O<sub>4</sub>@CMCS electrostatic, and Fe<sub>3</sub>O<sub>4</sub>@CMCS covalent for 0.5, 1, 2, 24, 48, and 72&#x02009;h. After the treatment, plates were equilibrated for 30&#x02009;min at room temperature and then 100&#x02009;<italic>&#x003bc;</italic>L of CellTiter-Glo reagent was added to each well. Plates were shaken for 2&#x02009;min and left at room temperature for 10&#x02009;min prior recording luminescent signals using the Infinite F200 plate reader (Tecan Group, Switzerland). Cell viability, expressed as ATP content and normalized against control values, was recorded. All the experiments were performed in triplicate.</p></sec><sec id="sec2.8"><title>2.8. Cellular Uptake</title><p>10<sup>4</sup> cells were seeded on a coverslip (12&#x02009;mm &#x000d8;) into 12-well assay plate and cultivated for 24&#x02009;h at 37&#x000b0;C in 5% CO<sub>2</sub> to equilibrate and become attached before treatment. Cells were then incubated for 4 or 24&#x02009;h with 25, 50, and 100&#x02009;<italic>&#x003bc;</italic>g/mL Fe<sub>3</sub>O<sub>4</sub>@heparin, Fe<sub>3</sub>O<sub>4</sub>@CMCS electrostatic, and Fe<sub>3</sub>O<sub>4</sub>@CMCS covalent and visualized by Prussian blue staining for iron detection. For this microscopic technique, the cells were fixed in ice-cold ethanol for 5&#x02009;min, stained with an equal volume of 2% hydrochloric acid and 2% potassium ferrocyanide trihydrate for 15&#x02009;min, and counterstained with 0.5% neutral red for 3&#x02009;min. The preparations were then washed with distilled water and dried by increasing concentrations of ethanol, than mounted in DePeX (Serva, Germany). Observations were performed by a Zeiss Axiophot microscope under bright light illumination and photographs were acquired by a Zeiss AxioCam ERc5s camera. </p><p>Furthermore, for TEM studies, 10<sup>6</sup> cells, seeded in a 10&#x02009;cm Petri dish, are exposed to 40&#x02009;<italic>&#x003bc;</italic>g/mL of NP@heparin, Fe<sub>3</sub>O<sub>4</sub>@CMCS electrostatic, and Fe<sub>3</sub>O<sub>4</sub>@CMCS covalent, for 30&#x02009;min or 3&#x02009;h. Then cells were harvested, fixed in 2% glutaraldehyde in 0.1&#x02009;M sodium cacodylate buffer (pH 7.2) for 10&#x02009;min on ice and for 30&#x02009;min at room temperature, washed in the same buffer, and postfixed in dark for 1&#x02009;h with 1% osmium tetroxide in 0.1&#x02009;M sodium-cacodylate buffer (pH 7.2) at room temperature. After dehydration standard steps with a series ethyl alcohol, samples were embedded in an Epon-Araldite 812 1&#x02009;:&#x02009;1 mixture. Thin sections (90&#x02009;nm), obtained with a ReichertUltracut S Ultratome (Leica, Nussloch, Germany), were stained with uranyl acetate and lead citrate according to the standard methods and observed with a Jeol 1010 electron microscope (Jeol, Tokyo, Japan) operated at 90&#x02009;keV.</p></sec><sec id="sec2.9"><title>2.9. Statistical Analysis</title><p>Cell viability values were expressed as mean &#x000b1; standard error (SE). Analysis of variance (two-way ANOVA), for balanced mixed-effect experiments (uncoated NPs, coated NPs, and exposure times), was performed using KaleidaGraph 4.0 (Synergy Software). Statistical significant differences were fixed at <italic>P</italic> &#x02264; 0.05 (*), <italic>P</italic> &#x02264; 0.01 (**), and <italic>P</italic> &#x02264; 0.005 (***).</p></sec></sec><sec id="sec3"><title>3. Results</title><sec id="sec3.1"><title>3.1. Nanoparticles Characterization</title><p>To confirm the characteristics reported on the product label by Sigma-Aldrich, we have measured Fe<sub>3</sub>O<sub>4</sub>NPs diameter. <italic>D</italic>
<sub>TEM</sub> was 25.08&#x02009;nm &#x000b1; SD 4.09. The amount of Fe released from Fe<sub>3</sub>O<sub>4</sub>NPs, or Fe<sub>3</sub>O<sub>4</sub>@heparin, or Fe<sub>3</sub>O<sub>4</sub>@CMCS-electrostatic bound or Fe<sub>3</sub>O<sub>4</sub>@CMCS-covalent bound, in our experimental conditions, was under the limit of detection of the method (0.02&#x02009;ppm).</p></sec><sec id="sec3.2"><title>3.2. FT-IR Spectra Analysis</title><p>In <xref ref-type="fig" rid="fig2">Figure 2</xref>, we have reported, as example, the FT-IR spectra of Fe<sub>3</sub>O<sub>4</sub>NPs (A) and Fe<sub>3</sub>O<sub>4</sub>@heparin (B). Spectrum (B) shows, at 591&#x02009;cm<sup>&#x02212;1</sup>, the characteristic peak of Fe&#x02013;O stretch, while, between 1000 and 1400&#x02009;cm<sup>&#x02212;1</sup>, peaks associated to C&#x02013;O and C&#x02013;C bonds due to the presence of heparin are present. Other peaks at 814, 1225, and 1612&#x02009;cm<sup>&#x02212;1</sup> can be assigned to the stretching of &#x02013;C&#x02013;O&#x02013;S, &#x02013;S=O, and &#x02013;COO<sup>&#x02212;</sup> of the sulphates and carboxylate groups. Lambda shifts toward lower values compared to heparin alone are probably ascribable to the interaction with iron oxide.</p><p>FT-IR spectra of chitosan (A) and CMCS (B) are shown in <xref ref-type="fig" rid="fig3">Figure 3</xref>. Spectrum A shows the basic characteristic peaks of chitosan: 3550&#x02009;cm<sup>&#x02212;1</sup> (O&#x02013;H stretch), 2930&#x02009;cm<sup>&#x02212;1</sup> (C&#x02013;H stretch), 1648&#x02009;cm<sup>&#x02212;1</sup> (NH bending), 1405&#x02009;cm<sup>&#x02212;1</sup> (O&#x02013;H bending), and 1080&#x02009;cm<sup>&#x02212;1</sup> (C&#x02013;O stretch). In addition to the peaks at 3550, 2930, 1405, and 1080&#x02009;cm<sup>&#x02212;1</sup>, CMCS spectrum (B) reports an expanded and intense peak at 1612&#x02009;cm<sup>&#x02212;1</sup> probably due to the overlapping of the signals of NH bending (1648&#x02009;cm<sup>&#x02212;1</sup>) and COO<sup>&#x02212;</sup> (1598&#x02009;cm<sup>&#x02212;1</sup>) [<xref rid="B23" ref-type="bibr">23</xref>]. </p><p>Fe<sub>3</sub>O<sub>4</sub>NPs (A) and Fe<sub>3</sub>O<sub>4</sub>@CMCS (B) spectra are shown in <xref ref-type="fig" rid="fig4">Figure 4</xref>. In spectrum A, the peak at 561&#x02009;cm<sup>&#x02212;1</sup> is that characteristic of Fe&#x02013;O stretch. Spectrum B, beside to the peak at 561&#x02009;cm<sup>&#x02212;1</sup>, reports the absorbance of CMCS molecule, in particular 1067&#x02009;cm<sup>&#x02212;1</sup> (C&#x02013;O stretch), 1406&#x02009;cm<sup>&#x02212;1</sup> (O&#x02013;H bend), 1608&#x02009;cm<sup>&#x02212;1</sup> (overlapping of the peaks of NH<sub>2</sub>, COOH, and COO<sup>&#x02212;</sup>), and 3550&#x02009;cm<sup>&#x02212;1</sup> (O&#x02013;H stretch). No significant differences were observed between spectra of Fe<sub>3</sub>O<sub>4</sub>@CMCS electrostatically and covalently bound.</p></sec><sec id="sec3.3"><title>3.3. Cell Viability after NP@heparin Treatment</title><p>As reported in <xref ref-type="fig" rid="fig5">Figure 5(a)</xref>, heparin alone was not toxic in the examined concentration range. A dose- and time-dependent reduction in cell viability was observed for all the examined NP systems, although Fe<sub>3</sub>O<sub>4</sub>NPs appear less toxic than Co<sub>3</sub>O<sub>4</sub> NPs which is less toxic than NiO NPs, see Figures <xref ref-type="fig" rid="fig6">6(a)</xref>, <xref ref-type="fig" rid="fig7">7(a)</xref>, and <xref ref-type="fig" rid="fig8">8(a)</xref>.</p><p>Regarding the comparison between uncoated and coated NPs, our data indicate that the coating did not decrease the NPs toxicity. As demonstrated in <xref ref-type="fig" rid="fig6">Figure 6</xref>, Co<sub>3</sub>O<sub>4</sub>NPs were less toxic than Co<sub>3</sub>O<sub>4</sub>@heparin for all the examined concentrations and time of treatment. The differences were less indicative for Fe<sub>3</sub>O<sub>4</sub>NPs and NiO NPs (Figures <xref ref-type="fig" rid="fig7">7</xref> and <xref ref-type="fig" rid="fig8">8</xref>). For further details, see Supplementary Material Tables 1, 2, and 3 available online at <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1155/2013/314091">http://dx.doi.org/10.1155/2013/314091</ext-link>.</p></sec><sec id="sec3.4"><title>3.4. Cell Viability after Fe<sub>3</sub>O<sub>4</sub>@CMCS Treatment</title><p>The ATP content of SKOV-3 treated with Fe<sub>3</sub>O<sub>4</sub>NPs, Fe<sub>3</sub>O<sub>4</sub>@CMCS-electrostatic, and Fe<sub>3</sub>O<sub>4</sub>@CMCS covalent are displayed in <xref ref-type="fig" rid="fig9">Figure 9</xref>. The percentage of CMCS bound to NPs was less than 4% of the total weight; therefore, it was reasonable to compare the amount of coated and uncoated Fe<sub>3</sub>O<sub>4</sub>NPs neglecting the weight of CMCS bound. As previously reported (<xref ref-type="fig" rid="fig5">Figure 5(b)</xref>), CMCS itself did not show cytotoxicity at the tested concentrations. On the contrary, Fe<sub>3</sub>O<sub>4</sub>@CMCS covalent, and electrostatic, caused a dose-dependent reduction of ATP (Figures <xref ref-type="fig" rid="fig9">9(a)</xref>, <xref ref-type="fig" rid="fig9">9(b)</xref> and <xref ref-type="fig" rid="fig9">9(c)</xref>) more pronounced compared to the bare Fe<sub>3</sub>O<sub>4</sub>NPs. For further details see Supplementary Material Table 4. </p></sec><sec id="sec3.5"><title>3.5. Cellular Uptake</title><p>Figures <xref ref-type="fig" rid="fig10">10(a)</xref>&#x02013;<xref ref-type="fig" rid="fig10">10(d)</xref> show the uptake of coated Fe<sub>3</sub>O<sub>4</sub>NPs by using the classical Prussian blue method. The cytoplasm is full of NPs around the nucleus but never inside. Fe<sub>3</sub>O<sub>4</sub>@heparin (<xref ref-type="fig" rid="fig10">Figure 10(d)</xref>) are more internalized compared to Fe<sub>3</sub>O<sub>4</sub>@CMCS covalent (<xref ref-type="fig" rid="fig10">Figure 10(b)</xref>) and electrostatic (<xref ref-type="fig" rid="fig10">Figure 10(c)</xref>). Apparently, no differences are observed between the two chitosan systems. Coated Fe<sub>3</sub>O<sub>4 </sub>NPs are readily incorporated into the cells already after 4&#x02009;h; therefore, it is not possible to assert a time and dose dependence. In addition, for all the NP systems, it is observed that internalized NP did not interfere with mitosis process (Figures <xref ref-type="fig" rid="fig10">10(b)</xref>&#x02013;<xref ref-type="fig" rid="fig10">10(d)</xref>).</p><p>TEM images (<xref ref-type="fig" rid="fig11">Figure 11</xref>) confirmed that NP@heparin are readily internalized; in fact, already after 30&#x02009;min of incubation NPs appeared inside the cells. Once entered most of the NPs remained in the cytoplasm, free or inside vesicles (Figures <xref ref-type="fig" rid="fig11">11(a)</xref>&#x02013;<xref ref-type="fig" rid="fig11">11(c)</xref>). As already highlighted by optical microscope, besides being rapid, internalization of the nanoparticles was aspecific. In these pictures, NP@heparin are identified as high electron density objects since NPs maintained the morphology observed in cell-free environment (<xref ref-type="fig" rid="fig11">Figure 11(d)</xref>). Worth to note is that, also after 3&#x02009;h of exposure, no NP@heparin was observed in the nuclei even though the massive internalization of NPs can modify nucleus shape (<xref ref-type="fig" rid="fig12">Figure 12</xref>). </p><p>From our observations, the internalization did not seem to be influenced by the coating. Our hypothesis is confirmed by TEM picture (<xref ref-type="fig" rid="fig13">Figure 13</xref>) that did not show appreciable differences in cellular localization between Fe<sub>3</sub>O<sub>4</sub>@CMCS electrostatically or covalently bound and NP@heparin (Figures <xref ref-type="fig" rid="fig11">11</xref> and <xref ref-type="fig" rid="fig12">12</xref>).</p></sec></sec><sec id="sec4"><title>4. Discussion</title><p>In recent years, the use of NPs, particularly MNPs, has expanded into biomedical research. Due to their unique properties such as small size, large surface area, and high reactivity, they are particularly suitable for diagnosis and therapy [<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B26" ref-type="bibr">26</xref>&#x02013;<xref rid="B29" ref-type="bibr">29</xref>]. Often, NPs have to be covered with molecules to get a core@shell system capable to bind bioactive molecules, stable in physiological fluids and possibly not toxic to the body. Among the innumerable coating materials, polymers such as heparin, dextran, carboxydextran, chitosan, and polyethylene glycol are considered more advantageous to satisfy the above-mentioned characteristics [<xref rid="B30" ref-type="bibr">30</xref>&#x02013;<xref rid="B33" ref-type="bibr">33</xref>].</p><p>In particular, the literature reports several applications of NPs covered with heparin, ranging from use as imaging agent to apoptosis-induced agent in cancer cell, as well as components of nanodevices [<xref rid="B34" ref-type="bibr">34</xref>&#x02013;<xref rid="B36" ref-type="bibr">36</xref>]. Unfortunately, this wide number of publications does not include toxicity studies of the synthesized systems. In particular, the literature lacks data on the comparison between the toxicity of core and core@shell. To try to fill this gap, in our laboratory, we have studied the characteristics and behavior of Co<sub>3</sub>O<sub>4</sub>, Fe<sub>3</sub>O<sub>4</sub>, and NiO NPs covered with heparin.</p><p>From our experiments resulted that the coating had significantly increased the colloid stability and hydrophilic property of metal NPs. In fact, the systems NP@heparin did not agglomerated thanks to the presence of negatively charged groups around the metallic core. The experiments on cytotoxicity, performed on SKOV-3 cells, have shown that heparin itself was not toxic within the range of the examined concentrations (see <xref ref-type="fig" rid="fig5">Figure 5(a)</xref>). Furthermore, as expected, Fe<sub>3</sub>O<sub>4</sub>@heparin was the less toxic system, while NiO@heparin was the most toxic one. Contrary to what one would expect, NP@heparin had not been found less toxic compared to the naked NPs for all the examined metals (see Figures <xref ref-type="fig" rid="fig6">6</xref>, <xref ref-type="fig" rid="fig7">7</xref>, and <xref ref-type="fig" rid="fig8">8</xref>). Depletion of ATP content, observed in these experiments, could be due to the massive internalization of NP@heparin by the cells, phenomenon substantiated by Prussian blue staining for iron detection. Nevertheless, at the concentrations used in these experiments, internalized Fe<sub>3</sub>O<sub>4</sub>@heparin did not arrest mitosis process and nanoparticles were shared between the daughter cells. Further analysis by TEM have demonstrated that NP@heparin were already present inside the cell after 30 min of exposure (Figures <xref ref-type="fig" rid="fig11">11(a)</xref>, <xref ref-type="fig" rid="fig11">11(b)</xref>, and <xref ref-type="fig" rid="fig11">11(c)</xref>). In this work, we have not investigated the mechanisms of internalization even though, as shown in Figures <xref ref-type="fig" rid="fig11">11(a)</xref>, <xref ref-type="fig" rid="fig11">11(b)</xref>, and <xref ref-type="fig" rid="fig11">11(c)</xref> and as reported by the literature [<xref rid="B37" ref-type="bibr">37</xref>&#x02013;<xref rid="B39" ref-type="bibr">39</xref>], endocytosis is certainly a possible way. Notwithstanding in our previous work we had observed the presence of NPs also in the mitochondria and in the nuclei [<xref rid="B40" ref-type="bibr">40</xref>], in these experiments NPs were confined only in cytoplasmic vesicles, even though, sometimes, the vesicle size was so enormous to modify nuclear shape and/or cause mechanical damages to the cell (see <xref ref-type="fig" rid="fig12">Figure 12</xref>). When the endocitotic vesicles had sizes that did not justify the mechanical damage, we could assume that cell toxicity could be due to the release of metal ions by the NP system; this hypothesis was supported by the data of cell viability in which Fe<sub>3</sub>O<sub>4</sub> NPs resulted the least toxic metal.</p><p>Chitosan, but even better CMCS, preferred because the carboxymethylation increases the chitosan solubility in physiological fluids, is widely studied for theranostic applications [<xref rid="B41" ref-type="bibr">41</xref>, <xref rid="B42" ref-type="bibr">42</xref>]. Despite the Prussian blue staining indicated that Fe<sub>3</sub>O<sub>4</sub>@chitosan uptake was less efficient compared to that of Fe<sub>3</sub>O<sub>4</sub>@heparin, TEM analysis showed that no differences were noticeable between the two NP systems. Furthermore, as previously reported for heparin, the presence of negative charges on NP surface enhances interactions with the cell membrane facilitating cellular uptake [<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B38" ref-type="bibr">38</xref>]. Thanks to its biocompatibility and the presence of active functional groups (amino, carboxyl, and hydroxyl), CMCS is a valid instrument to design novel biocompatible materials with tailored chemical and biophysical properties [<xref rid="B43" ref-type="bibr">43</xref>&#x02013;<xref rid="B46" ref-type="bibr">46</xref>]. Despite the wide use of CMCS little or nothing is known about its behavior when it is associated with metal NPs. This lack of data suggested us to evaluate the properties and the potential toxicity of the system Fe<sub>3</sub>O<sub>4</sub>@CMCS itself and compared to the naked Fe<sub>3</sub>O<sub>4</sub>NPs. For our studies, we have set up two different systems: Fe<sub>3</sub>O<sub>4</sub>@CMCS-electrostatic bound and Fe<sub>3</sub>O<sub>4</sub>@CMCS-covalent bound. The interest in coating Fe<sub>3</sub>O<sub>4</sub>NPs by covalent bond resided in an attempt to get a system characterized by a more stable shell in hydrophilic fluids. </p><p>Our studies on cell viability confirmed the biocompatibility of free CMCS at the tested conditions. When cells are exposed to Fe<sub>3</sub>O<sub>4</sub>@CMCS electrostatic, viability decreases with the same trend of Fe<sub>3</sub>O<sub>4</sub>NPs treatment (Figures <xref ref-type="fig" rid="fig9">9(a)</xref> and <xref ref-type="fig" rid="fig9">9(b)</xref>). The higher toxicity observed for Fe<sub>3</sub>O<sub>4</sub>@CMCS-covalent bond (<xref ref-type="fig" rid="fig9">Figure 9(c)</xref>) suggested that the method of preparation of the NPs could influence the cellular response.</p><p>Also in this case, uptake by SKOV-3 cells was relevant showing massive internalization already after 30&#x02009;min with NPs stored in cytoplasmic vesicles (<xref ref-type="fig" rid="fig13">Figure 13</xref>) with no detectable difference between NP@heparin and Fe<sub>3</sub>O<sub>4</sub>@CMCS.</p><p>Our results have confirmed the data present in the literature about the biocompatibility of heparin and CMCS and their capability to get stable suspensions in hydrophilic fluids when conjugated to metal NPs, but not the ability to reduce the cytotoxicity of metal NPs coated with these polymers. Nevertheless, it is difficult to compare data derived from different experimental conditions such as different concentration ranges rather than diverse cell types which can give diverse responses to the same treatment [<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B47" ref-type="bibr">47</xref>]. Moreover, the published data are often related to the whole system prepared and not to the single component, as we did, then the comparison is very difficult if not impossible.</p><p>In conclusion, the reactive groups, present on the surface of core@shell systems that we have synthesized, provide the opportunity for further functionalization so that a variety of biomolecules may be immobilized to enhance specific cell recognition for their use in targeting studies. Moreover, as regards Fe<sub>3</sub>O<sub>4</sub>NPs, even though the coating does not reduce their toxicity, the amount of NPs present in the systems is usually so low to render their toxicity negligible. Furthermore, due to their magnetic properties, Fe<sub>3</sub>O<sub>4</sub>NPs can be directed to the site of interest thanks to an external magnet. From this point of view, they could be promising tools as drug carrier for diagnosis and therapy.</p></sec><sec sec-type="supplementary-material" id="supplementary-material-sec"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="f1"><caption><p>We have evaluated by two way ANOVA the cytotoxicity data which are plotted in the text figures.. Differences in cytotoxicity due to exposure time resulted almost always significant. Those due to coating resulted definitely significant only for Co<sub>3</sub>O<sub>4</sub> NPs vs Co<sub>3</sub>O<sub>4</sub>@heparinand and Fe<sub>3</sub>O<sub>4</sub> NPs vs Fe3O4@CMCS.</p></caption><media xlink:href="314091.f1.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><title>Conflict of Interests</title><p>No conflict of interests is present. The authors have no financial involvement or interest with any organization or company about subjects or materials discussed in the paper.</p></ack><ack><title>Acknowledgments</title><p>A. Bava was supported by Consorzio Interuniversitario Biotecnologie and by Associazione Amici dell'Universit&#x000e0; grants.</p></ack><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cattaneo</surname><given-names>AG</given-names></name><name><surname>Gornati</surname><given-names>R</given-names></name><name><surname>Sabbioni</surname><given-names>E</given-names></name><etal/></person-group><article-title>Nanotechnology and human health: risks and benefits</article-title><source><italic>Journal of Applied Toxicology</italic></source><year>2010</year><volume>30</volume><issue>8</issue><fpage>730</fpage><lpage>744</lpage><pub-id pub-id-type="other">2-s2.0-78649681338</pub-id><pub-id pub-id-type="pmid">21117037</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eidi</surname><given-names>H</given-names></name><name><surname>Joubert</surname><given-names>O</given-names></name><name><surname>Attik</surname><given-names>G</given-names></name><etal/></person-group><article-title>Cytotoxicity assessment of heparin nanoparticles in NR8383 macrophages</article-title><source><italic>International Journal of Pharmaceutics</italic></source><year>2010</year><volume>396</volume><issue>1-2</issue><fpage>156</fpage><lpage>165</lpage><pub-id pub-id-type="other">2-s2.0-77955053327</pub-id><pub-id pub-id-type="pmid">20542101</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kemp</surname><given-names>MM</given-names></name><name><surname>Linhardt</surname><given-names>RJ</given-names></name></person-group><article-title>Heparin-based nanoparticles</article-title><source><italic>Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology</italic></source><year>2010</year><volume>2</volume><issue>1</issue><fpage>77</fpage><lpage>87</lpage><pub-id pub-id-type="other">2-s2.0-77953662783</pub-id><pub-id pub-id-type="pmid">20049832</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mourya</surname><given-names>VK</given-names></name><name><surname>Inamdar</surname><given-names>NN</given-names></name><name><surname>Tiwari</surname><given-names>A</given-names></name></person-group><article-title>Carboxymethyl chitosan and its applications</article-title><source><italic>Advanced Materials Letters</italic></source><year>2010</year><volume>1</volume><issue>1</issue><fpage>11</fpage><lpage>33</lpage></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riva</surname><given-names>R</given-names></name><name><surname>Ragelle</surname><given-names>H</given-names></name><name><surname>des Rieux</surname><given-names>A</given-names></name><name><surname>Duhem</surname><given-names>N</given-names></name><name><surname>J&#x000e9;r&#x000f4;me</surname><given-names>C</given-names></name><name><surname>Pr&#x000e9;at</surname><given-names>V</given-names></name></person-group><article-title>Chitosan and chitosan derivatives in drug delivery and tissue engineering</article-title><source><italic>Advances in Polymer Science</italic></source><year>2011</year><volume>244</volume><fpage>19</fpage><lpage>44</lpage></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>A</given-names></name><name><surname>Yuan</surname><given-names>L</given-names></name><name><surname>Liao</surname><given-names>T</given-names></name></person-group><article-title>Suspension of Fe<sub>3</sub>O<sub>4</sub> nanoparticles stabilized by chitosan and o-carboxymethylchitosan</article-title><source><italic>International Journal of Pharmaceutics</italic></source><year>2008</year><volume>350</volume><issue>1-2</issue><fpage>361</fpage><lpage>368</lpage><pub-id pub-id-type="other">2-s2.0-38349164373</pub-id><pub-id pub-id-type="pmid">17931808</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>HY</given-names></name><name><surname>Kim</surname><given-names>IS</given-names></name><name><surname>Kwon</surname><given-names>IC</given-names></name><name><surname>Kim</surname><given-names>YH</given-names></name></person-group><article-title>Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles</article-title><source><italic>Journal of Controlled Release</italic></source><year>2008</year><volume>128</volume><issue>1</issue><fpage>23</fpage><lpage>31</lpage><pub-id pub-id-type="other">2-s2.0-42749096481</pub-id><pub-id pub-id-type="pmid">18374444</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dinarvand</surname><given-names>R</given-names></name><name><surname>Sepehri</surname><given-names>N</given-names></name><name><surname>Manoochehri</surname><given-names>S</given-names></name><name><surname>Rouhani</surname><given-names>H</given-names></name><name><surname>Atyabi</surname><given-names>F</given-names></name></person-group><article-title>Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents</article-title><source><italic>International Journal of Nanomedicine</italic></source><year>2011</year><volume>6</volume><fpage>877</fpage><lpage>895</lpage><pub-id pub-id-type="pmid">21720501</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mora-Huertas</surname><given-names>CE</given-names></name><name><surname>Fessi</surname><given-names>H</given-names></name><name><surname>Elaissari</surname><given-names>A</given-names></name></person-group><article-title>Polymer-based nanocapsules for drug delivery</article-title><source><italic>International Journal of Pharmaceutics</italic></source><year>2010</year><volume>385</volume><issue>1-2</issue><fpage>113</fpage><lpage>142</lpage><pub-id pub-id-type="other">2-s2.0-72449153806</pub-id><pub-id pub-id-type="pmid">19825408</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bava</surname><given-names>A</given-names></name><name><surname>Gornati</surname><given-names>R</given-names></name><name><surname>Cappellini</surname><given-names>F</given-names></name><name><surname>Caldinelli</surname><given-names>L</given-names></name><name><surname>Pollegioni</surname><given-names>L</given-names></name><name><surname>Bernardini</surname><given-names>G</given-names></name></person-group><article-title>D-amino acid oxidase-nanoparticle system: a potential novel approach for cancer enzymatic therapy</article-title><source><italic>Nanomedicine</italic></source><year>2013</year></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nel</surname><given-names>A</given-names></name><name><surname>Xia</surname><given-names>T</given-names></name><name><surname>M&#x000e4;dler</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>N</given-names></name></person-group><article-title>Toxic potential of materials at the nanolevel</article-title><source><italic>Science</italic></source><year>2006</year><volume>311</volume><issue>5761</issue><fpage>622</fpage><lpage>627</lpage><pub-id pub-id-type="other">2-s2.0-31944451232</pub-id><pub-id pub-id-type="pmid">16456071</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Nalwa</surname><given-names>HS</given-names></name></person-group><article-title>Nanotechnology and health safety - Toxicity and risk assessments of nanostructured materials on human health</article-title><source><italic>Journal of Nanoscience and Nanotechnology</italic></source><year>2007</year><volume>7</volume><issue>9</issue><fpage>3048</fpage><lpage>3070</lpage><pub-id pub-id-type="other">2-s2.0-38449121604</pub-id><pub-id pub-id-type="pmid">18019130</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papis</surname><given-names>E</given-names></name><name><surname>Gornati</surname><given-names>R</given-names></name><name><surname>Ponti</surname><given-names>J</given-names></name><name><surname>Prati</surname><given-names>M</given-names></name><name><surname>Sabbioni</surname><given-names>E</given-names></name><name><surname>Bernardini</surname><given-names>G</given-names></name></person-group><article-title>Gene expression in nanotoxicology: a search for biomarkers of exposure to cobalt particles and ions</article-title><source><italic>Nanotoxicology</italic></source><year>2007</year><volume>1</volume><issue>3</issue><fpage>198</fpage><lpage>203</lpage><pub-id pub-id-type="other">2-s2.0-36549025918</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papis</surname><given-names>E</given-names></name><name><surname>Gornati</surname><given-names>R</given-names></name><name><surname>Prati</surname><given-names>M</given-names></name><name><surname>Ponti</surname><given-names>J</given-names></name><name><surname>Sabbioni</surname><given-names>E</given-names></name><name><surname>Bernardini</surname><given-names>G</given-names></name></person-group><article-title>Gene expression in nanotoxicology research: analysis by differential display in BALB3T3 fibroblasts exposed to cobalt particles and ions</article-title><source><italic>Toxicology Letters</italic></source><year>2007</year><volume>170</volume><issue>3</issue><fpage>185</fpage><lpage>192</lpage><pub-id pub-id-type="other">2-s2.0-34248171743</pub-id><pub-id pub-id-type="pmid">17412531</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Gioacchino</surname><given-names>M</given-names></name><name><surname>Verna</surname><given-names>N</given-names></name><name><surname>Di Giampaolo</surname><given-names>L</given-names></name><etal/></person-group><article-title>Immunotoxicity and sensitizing capacity of metal compounds depend on speciation</article-title><source><italic>International Journal of Immunopathology and Pharmacology</italic></source><year>2007</year><volume>20</volume><issue>2</issue><fpage>15</fpage><lpage>22</lpage><pub-id pub-id-type="other">2-s2.0-38449093546</pub-id><pub-id pub-id-type="pmid">17903351</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munoz</surname><given-names>A</given-names></name><name><surname>Costa</surname><given-names>M</given-names></name></person-group><article-title>Elucidating the mechanisms of nickel compound uptake: a review of particulate and nano-nickel endocytosis and toxicity</article-title><source><italic>Toxicology and Applied Pharmacology</italic></source><year>2012</year><volume>260</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">22206756</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cattaneo</surname><given-names>AG</given-names></name><name><surname>Gornati</surname><given-names>R</given-names></name><name><surname>Chiriva-Internati</surname><given-names>M</given-names></name><name><surname>Bernardini</surname><given-names>G</given-names></name></person-group><article-title>Ecotoxicology of nanomaterials: the role of invertebrate testing</article-title><source><italic>Invertebrate Survival Journal</italic></source><year>2009</year><volume>6</volume><fpage>78</fpage><lpage>97</lpage></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Wen</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name></person-group><article-title>Chitosan nanoparticles inhibit the growth of human hepatocellular carcinoma xenografts through an antiangiogenic mechanism</article-title><source><italic>Anticancer Research</italic></source><year>2009</year><volume>29</volume><issue>12</issue><fpage>5103</fpage><lpage>5109</lpage><pub-id pub-id-type="other">2-s2.0-75149149835</pub-id><pub-id pub-id-type="pmid">20044623</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poizot</surname><given-names>P</given-names></name><name><surname>Laruelle</surname><given-names>S</given-names></name><name><surname>Grugeon</surname><given-names>S</given-names></name><name><surname>Dupont</surname><given-names>L</given-names></name><name><surname>Tarascon</surname><given-names>JM</given-names></name></person-group><article-title>Nano-sized transition-metal oxides as negative-electrode materials for lithium-ion batteries</article-title><source><italic>Nature</italic></source><year>2000</year><volume>407</volume><issue>6803</issue><fpage>496</fpage><lpage>499</lpage><pub-id pub-id-type="other">2-s2.0-0034727086</pub-id><pub-id pub-id-type="pmid">11028997</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pach&#x000f3;n</surname><given-names>LD</given-names></name><name><surname>Rothenberg</surname><given-names>G</given-names></name></person-group><article-title>Transition-metal nanoparticles: synthesis, stability and the leaching issue</article-title><source><italic>Applied Organometallic Chemistry</italic></source><year>2008</year><volume>22</volume><issue>6</issue><fpage>288</fpage><lpage>299</lpage><pub-id pub-id-type="other">2-s2.0-52949084007</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreno-Ma&#x000f1;as</surname><given-names>M</given-names></name><name><surname>Pleixats</surname><given-names>R</given-names></name></person-group><article-title>Formation of carbon-carbon bonds under catalysis by transition-metal nanoparticles</article-title><source><italic>Accounts of Chemical Research</italic></source><year>2003</year><volume>36</volume><issue>8</issue><fpage>638</fpage><lpage>643</lpage><pub-id pub-id-type="other">2-s2.0-0042975158</pub-id><pub-id pub-id-type="pmid">12924961</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rafique</surname><given-names>S</given-names></name><name><surname>Idrees</surname><given-names>M</given-names></name><name><surname>Nasim</surname><given-names>A</given-names></name><name><surname>Akbar</surname><given-names>H</given-names></name><name><surname>Athar</surname><given-names>A</given-names></name></person-group><article-title>Transition metal complexes as potential therapeutic agents</article-title><source><italic>Biotechnology and Molecular Biology Reviews</italic></source><year>2010</year><volume>5</volume><issue>2</issue><fpage>38</fpage><lpage>45</lpage></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>A</given-names></name><name><surname>Chan-Park</surname><given-names>MB</given-names></name><name><surname>Dai</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>L</given-names></name></person-group><article-title>The aggregation behavior of O-carboxymethylchitosan in dilute aqueous solution</article-title><source><italic>Colloids and Surfaces B</italic></source><year>2005</year><volume>43</volume><issue>3-4</issue><fpage>143</fpage><lpage>149</lpage><pub-id pub-id-type="other">2-s2.0-21344453292</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>YY</given-names></name><name><surname>Zhang</surname><given-names>LM</given-names></name></person-group><article-title>Bioconjugation of papain on superparamagnetic nanoparticles decorated with carboxymethylated chitosan</article-title><source><italic>Biomacromolecules</italic></source><year>2007</year><volume>8</volume><issue>5</issue><fpage>1480</fpage><lpage>1486</lpage><pub-id pub-id-type="other">2-s2.0-34249890779</pub-id><pub-id pub-id-type="pmid">17385911</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kester</surname><given-names>DR</given-names></name><name><surname>Duedall</surname><given-names>IW</given-names></name><name><surname>Connors</surname><given-names>DN</given-names></name><name><surname>Pytkowicz</surname><given-names>RM</given-names></name></person-group><article-title>Preparation of artificial sea water</article-title><source><italic>Limnology and Oceanography</italic></source><year>1967</year><volume>12</volume><issue>1</issue><fpage>176</fpage><lpage>179</lpage></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharya</surname><given-names>R</given-names></name><name><surname>Mukherjee</surname><given-names>P</given-names></name></person-group><article-title>Biological properties of "naked" metal nanoparticles</article-title><source><italic>Advanced Drug Delivery Reviews</italic></source><year>2008</year><volume>60</volume><issue>11</issue><fpage>1289</fpage><lpage>1306</lpage><pub-id pub-id-type="other">2-s2.0-46949107983</pub-id><pub-id pub-id-type="pmid">18501989</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conde</surname><given-names>J</given-names></name><name><surname>Doria</surname><given-names>G</given-names></name><name><surname>Baptista</surname><given-names>P</given-names></name></person-group><article-title>Noble metal nanoparticles applications in cancer</article-title><source><italic>Journal of Drug Delivery</italic></source><year>2012</year><volume>2012</volume><fpage>12 pages</fpage><pub-id pub-id-type="publisher-id">751075</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez-Hurtado</surname><given-names>JL</given-names></name></person-group><article-title>Metallic nanoparticle block copolymer vesicles with enhanced optical properties</article-title><source><italic>Nanomaterials</italic></source><year>2011</year><volume>1</volume><fpage>20</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">28348278</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tartaj</surname><given-names>P</given-names></name><name><surname>Del Puerto Morales</surname><given-names>M</given-names></name><name><surname>Veintemillas-Verdaguer</surname><given-names>S</given-names></name><name><surname>Gonz&#x000e1;lez-Carre&#x000f1;o</surname><given-names>T</given-names></name><name><surname>Serna</surname><given-names>CJ</given-names></name></person-group><article-title>The preparation of magnetic nanoparticles for applications in biomedicine</article-title><source><italic>Journal of Physics D</italic></source><year>2003</year><volume>36</volume><issue>13</issue><fpage>R182</fpage><lpage>R197</lpage><pub-id pub-id-type="other">2-s2.0-0038444472</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kemp</surname><given-names>MM</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Mousa</surname><given-names>S</given-names></name><etal/></person-group><article-title>Synthesis of gold and silver nanoparticles stabilized with glycosaminoglycans having distinctive biological activities</article-title><source><italic>Biomacromolecules</italic></source><year>2009</year><volume>10</volume><issue>3</issue><fpage>589</fpage><lpage>595</lpage><pub-id pub-id-type="other">2-s2.0-65249119638</pub-id><pub-id pub-id-type="pmid">19226107</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khurshid</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Bonder</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Development of heparin-coated magnetic nanoparticles for targeted drug delivery applications</article-title><source><italic>Journal of Applied Physics</italic></source><year>2009</year><volume>105</volume><issue>7</issue><fpage>3 pages</fpage><pub-id pub-id-type="other">2-s2.0-65249123012</pub-id><pub-id pub-id-type="publisher-id">07B308</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>C</given-names></name><name><surname>Lee</surname><given-names>JSH</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name></person-group><article-title>Magnetic nanoparticles in MR imaging and drug delivery</article-title><source><italic>Advanced Drug Delivery Reviews</italic></source><year>2008</year><volume>60</volume><issue>11</issue><fpage>1252</fpage><lpage>1265</lpage><pub-id pub-id-type="other">2-s2.0-46749142847</pub-id><pub-id pub-id-type="pmid">18558452</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veiseh</surname><given-names>O</given-names></name><name><surname>Gunn</surname><given-names>JW</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name></person-group><article-title>Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging</article-title><source><italic>Advanced Drug Delivery Reviews</italic></source><year>2010</year><volume>62</volume><issue>3</issue><fpage>284</fpage><lpage>304</lpage><pub-id pub-id-type="other">2-s2.0-76749093968</pub-id><pub-id pub-id-type="pmid">19909778</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>DY</given-names></name></person-group><article-title>Highly effective T2 MR contrast agent based on heparinized superparamagnetic iron oxide nanoparticles</article-title><source><italic>Macromolecular Research</italic></source><year>2011</year><volume>19</volume><issue>8</issue><fpage>843</fpage><lpage>847</lpage></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Bae</surname><given-names>KH</given-names></name><name><surname>Park</surname><given-names>TG</given-names></name></person-group><article-title>Heparin immobilized gold nanoparticles for targeted detection and apoptotic death of metastatic cancer cells</article-title><source><italic>Biomaterials</italic></source><year>2010</year><volume>31</volume><issue>25</issue><fpage>6530</fpage><lpage>6536</lpage><pub-id pub-id-type="other">2-s2.0-77953962218</pub-id><pub-id pub-id-type="pmid">20537379</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Min</surname><given-names>KA</given-names></name><name><surname>Yu</surname><given-names>F</given-names></name><name><surname>Yang</surname><given-names>VC</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Rosania</surname><given-names>GR</given-names></name></person-group><article-title>Transcellular transport of heparin-coated magnetic iron oxide nanoparticles (Hep-MION) under the influence of an applied magnetic field</article-title><source><italic>Pharmaceutics</italic></source><year>2010</year><volume>2</volume><issue>2</issue><fpage>119</fpage><lpage>135</lpage><pub-id pub-id-type="other">2-s2.0-79952137688</pub-id><pub-id pub-id-type="pmid">21152371</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villanueva</surname><given-names>A</given-names></name><name><surname>C&#x000e3;ete</surname><given-names>M</given-names></name><name><surname>Roca</surname><given-names>AG</given-names></name><etal/></person-group><article-title>The influence of surface functionalization on the enhanced internalization of magnetic nanoparticles in cancer cells</article-title><source><italic>Nanotechnology</italic></source><year>2009</year><volume>20</volume><issue>11</issue><fpage>9 pages</fpage><pub-id pub-id-type="other">2-s2.0-65449187581</pub-id><pub-id pub-id-type="publisher-id">115103</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabbioni</surname><given-names>E</given-names></name><name><surname>Fortaner</surname><given-names>S</given-names></name><name><surname>Farina</surname><given-names>M</given-names></name><etal/></person-group><article-title>Interaction with culture medium components, cellular uptake and intracellular distribution of cobalt nanoparticles, microparticles and ions in Balb/3T3 mouse fibroblasts</article-title><source><italic>Nanotoxicology</italic></source><year>2012</year></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilhelm</surname><given-names>C</given-names></name><name><surname>Gazeau</surname><given-names>F</given-names></name></person-group><article-title>Universal cell labelling with anionic magnetic nanoparticles</article-title><source><italic>Biomaterials</italic></source><year>2008</year><volume>29</volume><issue>22</issue><fpage>3161</fpage><lpage>3174</lpage><pub-id pub-id-type="other">2-s2.0-43549106765</pub-id><pub-id pub-id-type="pmid">18455232</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papis</surname><given-names>E</given-names></name><name><surname>Rossi</surname><given-names>F</given-names></name><name><surname>Raspanti</surname><given-names>M</given-names></name><etal/></person-group><article-title>Engineered cobalt oxide nanoparticles readily enter cells</article-title><source><italic>Toxicology Letters</italic></source><year>2009</year><volume>189</volume><issue>3</issue><fpage>253</fpage><lpage>259</lpage><pub-id pub-id-type="other">2-s2.0-67650084378</pub-id><pub-id pub-id-type="pmid">19539014</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arami</surname><given-names>H</given-names></name><name><surname>Stephen</surname><given-names>Z</given-names></name><name><surname>Veiseh</surname><given-names>O</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name></person-group><article-title>Chitosan-coated iron oxide nanoparticles for molecular imaging and drug delivery</article-title><source><italic>Advances in Polymer Science</italic></source><year>2011</year><volume>243</volume><fpage>63</fpage><lpage>184</lpage></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>XG</given-names></name><name><surname>Park</surname><given-names>HJ</given-names></name></person-group><article-title>Chemical characteristics of <italic>O</italic>-carboxymethyl chitosans related to the preparation conditions</article-title><source><italic>Carbohydrate Polymers</italic></source><year>2003</year><volume>53</volume><issue>4</issue><fpage>355</fpage><lpage>359</lpage><pub-id pub-id-type="other">2-s2.0-0042766279</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>AP</given-names></name><name><surname>Fang</surname><given-names>N</given-names></name><name><surname>Chan-Park</surname><given-names>MB</given-names></name><name><surname>Chan</surname><given-names>V</given-names></name></person-group><article-title>Interaction between O-carboxymethylchitosan and dipalmitoyl-sn-glycero-3- phosphocholine bilayer</article-title><source><italic>Biomaterials</italic></source><year>2005</year><volume>26</volume><issue>34</issue><fpage>6873</fpage><lpage>6879</lpage><pub-id pub-id-type="other">2-s2.0-23244467464</pub-id><pub-id pub-id-type="pmid">15972235</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agrawal</surname><given-names>P</given-names></name><name><surname>Strijkers</surname><given-names>GJ</given-names></name><name><surname>Nicolay</surname><given-names>K</given-names></name></person-group><article-title>Chitosan-based systems for molecular imaging</article-title><source><italic>Advanced Drug Delivery Reviews</italic></source><year>2010</year><volume>62</volume><issue>1</issue><fpage>42</fpage><lpage>58</lpage><pub-id pub-id-type="other">2-s2.0-75349088065</pub-id><pub-id pub-id-type="pmid">19861142</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharya</surname><given-names>D</given-names></name><name><surname>Das</surname><given-names>M</given-names></name><name><surname>Mishra</surname><given-names>D</given-names></name><etal/></person-group><article-title>Folate receptor targeted, carboxymethyl chitosan functionalized iron oxide nanoparticles: a novel ultradispersed nanoconjugates for bimodal imaging</article-title><source><italic>Nanoscale</italic></source><year>2011</year><volume>3</volume><issue>4</issue><fpage>1653</fpage><lpage>1662</lpage><pub-id pub-id-type="other">2-s2.0-79953765470</pub-id><pub-id pub-id-type="pmid">21331392</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trang Mai</surname><given-names>TT</given-names></name><name><surname>Ha</surname><given-names>PT</given-names></name><name><surname>Pham</surname><given-names>HN</given-names></name><etal/></person-group><article-title>Chitosan and O-carboxymethylchitosan modified Fe<sub>3</sub>O<sub>4</sub> for hyperthermic treatment</article-title><source><italic>Advances in Natural Sciences: Nanoscience and Nanotechnology</italic></source><year>2012</year><volume>3</volume><fpage>5 pages</fpage><pub-id pub-id-type="publisher-id">015006</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>CF</given-names></name><name><surname>Grainger</surname><given-names>DW</given-names></name></person-group><article-title>
<italic>In vitro</italic> assessments of nanomaterial toxicity</article-title><source><italic>Advanced Drug Delivery Reviews</italic></source><year>2009</year><volume>61</volume><issue>6</issue><fpage>438</fpage><lpage>456</lpage><pub-id pub-id-type="other">2-s2.0-65749087491</pub-id><pub-id pub-id-type="pmid">19383522</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Chemical structure of chitosan (A) and carboxymethylchitosan (B).</p></caption><graphic xlink:href="BMRI2013-314091.001"/></fig><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>FT-IR spectra of Fe<sub>3</sub>O<sub>4 </sub>NPs (A) and Fe<sub>3</sub>O<sub>4</sub>@heparin (B). The peaks at 814&#x02009;cm<sup>&#x02212;1</sup>, between 1000 and 1400&#x02009;cm<sup>&#x02212;1</sup> and those at 1225, and 1612&#x02009;cm<sup>&#x02212;1</sup> are indicative of the heparin coating. </p></caption><graphic xlink:href="BMRI2013-314091.002"/></fig><fig id="fig3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>FT-IR spectra chitosan (A) and CMCS (B). Chemical modification of chitosan is confirmed by the presence of the intense peak at 1612&#x02009;cm<sup>&#x02212;1</sup>, attributed to the overlapping of the signals of NH bending and &#x02013;COO<sup>&#x02212;</sup>.</p></caption><graphic xlink:href="BMRI2013-314091.003"/></fig><fig id="fig4" orientation="portrait" position="float"><label>Figure 4</label><caption><p>FT-IR spectra Fe<sub>3</sub>O<sub>4 </sub>NPs (A) and Fe<sub>3</sub>O<sub>4</sub>@CMCS (B). The peaks at 1067, 1406, 1608, and 3550&#x02009;cm<sup>&#x02212;1</sup> indicate the presence of CMCS on the Fe<sub>3</sub>O<sub>4</sub>NPs surface. </p></caption><graphic xlink:href="BMRI2013-314091.004"/></fig><fig id="fig5" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Percentage of ATP content, normalized to control, in SKOV-3 exposed to heparin (a) and carboxymethylchitosan (b) for different times.</p></caption><graphic xlink:href="BMRI2013-314091.005"/></fig><fig id="fig6" orientation="portrait" position="float"><label>Figure 6</label><caption><p>Percentage of ATP content, normalized to control, in SKOV-3 exposed to Co<sub>3</sub>O<sub>4 </sub>NPs (a) and Co<sub>3</sub>O<sub>4</sub>@heparin (b) for different times.</p></caption><graphic xlink:href="BMRI2013-314091.006"/></fig><fig id="fig7" orientation="portrait" position="float"><label>Figure 7</label><caption><p>Percentage of ATP content, normalized to control, in SKOV-3 exposed to Fe<sub>3</sub>O<sub>4 </sub>NPs (a) and Fe<sub>3</sub>O<sub>4</sub>@heparin (b) for different times.</p></caption><graphic xlink:href="BMRI2013-314091.007"/></fig><fig id="fig8" orientation="portrait" position="float"><label>Figure 8</label><caption><p>Percentage of ATP content, normalized to control, in SKOV-3 exposed to NiO NPs (a) and NiO@heparin (b) for different times.</p></caption><graphic xlink:href="BMRI2013-314091.008"/></fig><fig id="fig9" orientation="portrait" position="float"><label>Figure 9</label><caption><p>Percentage of ATP content, normalized to control, in SKOV-3 exposed to Fe<sub>3</sub>O<sub>4 </sub>NPs (a), Fe<sub>3</sub>O<sub>4</sub>@CMCS electrostatic (b), and Fe<sub>3</sub>O<sub>4</sub>@CMCS covalent (c) for different times.</p></caption><graphic xlink:href="BMRI2013-314091.009"/></fig><fig id="fig10" orientation="portrait" position="float"><label>Figure 10</label><caption><p>Uptake of SKOV-3 cells after 24&#x02009;h of incubation with 25&#x02009;mg/mL of anionic NPs. (a) Control cells; (b) Fe<sub>3</sub>O<sub>4</sub>@CMCS covalent; (c) Fe<sub>3</sub>O<sub>4</sub>@CMCS electrostatic; (d) Fe<sub>3</sub>O<sub>4</sub>@heparin. As shown in (b, c, and d) internalized NPs did not interfere with mitosis process. Magnification: 40x. </p></caption><graphic xlink:href="BMRI2013-314091.010"/></fig><fig id="fig11" orientation="portrait" position="float"><label>Figure 11</label><caption><p>TEM pictures of SKOV-3 cells exposed to Co<sub>3</sub>O<sub>4</sub>@heparin (a), Fe<sub>3</sub>O<sub>4</sub>@heparin (b), and NiO@heparin (c) for 30&#x02009;min. (d) A picture of Fe<sub>3</sub>O<sub>4</sub>@heparin deposited on a formvar carbon coated grid.</p></caption><graphic xlink:href="BMRI2013-314091.011"/></fig><fig id="fig12" orientation="portrait" position="float"><label>Figure 12</label><caption><p>TEM picture showing a large agglomerate of Co<sub>3</sub>O<sub>4</sub>@heparin which modifies the shape of a SKOV-3 nucleus. Cells were fixed after 30&#x02009;min of exposure. </p></caption><graphic xlink:href="BMRI2013-314091.012"/></fig><fig id="fig13" orientation="portrait" position="float"><label>Figure 13</label><caption><p>TEM pictures of SKOV-3 cells exposed for 30&#x02009;min to Fe<sub>3</sub>O<sub>4</sub>@CMCS electrostatic (a) and covalent (b).</p></caption><graphic xlink:href="BMRI2013-314091.013"/></fig></floats-group></article>